The company said the agency wouldn’t review its application on the grounds that the study testing the shot wasn’t sufficient.
Discover more from InfoVera USA
Subscribe to get the latest posts sent to your email.
US News, Trends & Trusted Information
The company said the agency wouldn’t review its application on the grounds that the study testing the shot wasn’t sufficient.
Subscribe to get the latest posts sent to your email.
Subscribe now to keep reading and get access to the full archive.